Clinical Trial Detail

NCT ID NCT03451825
Title Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

lymphoma

Therapies

Avelumab

Age Groups: adult child

No variant requirements are available.